GO:0018022 | peptidyl-lysine methylation | 20.24% (17/84) | 4.59 | 0.0 | 0.0 |
GO:0006259 | DNA metabolic process | 26.19% (22/84) | 3.7 | 0.0 | 0.0 |
GO:0034968 | histone lysine methylation | 20.24% (17/84) | 4.6 | 0.0 | 0.0 |
GO:0006479 | protein methylation | 20.24% (17/84) | 4.28 | 0.0 | 0.0 |
GO:0008213 | protein alkylation | 20.24% (17/84) | 4.28 | 0.0 | 0.0 |
GO:0016571 | histone methylation | 20.24% (17/84) | 4.3 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 42.86% (36/84) | 2.3 | 0.0 | 0.0 |
GO:0051567 | histone H3-K9 methylation | 16.67% (14/84) | 4.69 | 0.0 | 0.0 |
GO:0061647 | histone H3-K9 modification | 16.67% (14/84) | 4.69 | 0.0 | 0.0 |
GO:0018205 | peptidyl-lysine modification | 20.24% (17/84) | 4.04 | 0.0 | 0.0 |
GO:0016570 | histone modification | 20.24% (17/84) | 4.0 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 36.9% (31/84) | 2.47 | 0.0 | 0.0 |
GO:0018193 | peptidyl-amino acid modification | 20.24% (17/84) | 3.8 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 42.86% (36/84) | 2.08 | 0.0 | 0.0 |
GO:0032259 | methylation | 21.43% (18/84) | 3.55 | 0.0 | 0.0 |
GO:0043414 | macromolecule methylation | 21.43% (18/84) | 3.55 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 42.86% (36/84) | 2.0 | 0.0 | 0.0 |
GO:0031048 | heterochromatin assembly by small RNA | 13.1% (11/84) | 4.98 | 0.0 | 0.0 |
GO:0016458 | obsolete gene silencing | 10.71% (9/84) | 5.67 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 42.86% (36/84) | 1.93 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 44.05% (37/84) | 1.82 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 42.86% (36/84) | 1.86 | 0.0 | 0.0 |
GO:0010629 | negative regulation of gene expression | 17.86% (15/84) | 3.65 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 48.81% (41/84) | 1.57 | 0.0 | 0.0 |
GO:0006346 | DNA methylation-dependent heterochromatin assembly | 11.9% (10/84) | 4.71 | 0.0 | 0.0 |
GO:0006304 | DNA modification | 13.1% (11/84) | 4.38 | 0.0 | 0.0 |
GO:0070828 | heterochromatin organization | 13.1% (11/84) | 4.38 | 0.0 | 0.0 |
GO:0044728 | DNA methylation or demethylation | 13.1% (11/84) | 4.39 | 0.0 | 0.0 |
GO:0031507 | heterochromatin assembly | 13.1% (11/84) | 4.39 | 0.0 | 0.0 |
GO:0045814 | negative regulation of gene expression, epigenetic | 13.1% (11/84) | 4.35 | 0.0 | 0.0 |
GO:0022402 | cell cycle process | 19.05% (16/84) | 3.28 | 0.0 | 0.0 |
GO:0006325 | chromatin organization | 14.29% (12/84) | 3.93 | 0.0 | 0.0 |
GO:0006260 | DNA replication | 14.29% (12/84) | 3.93 | 0.0 | 0.0 |
GO:0040029 | regulation of gene expression, epigenetic | 13.1% (11/84) | 4.17 | 0.0 | 0.0 |
GO:0010605 | negative regulation of macromolecule metabolic process | 19.05% (16/84) | 3.1 | 0.0 | 0.0 |
GO:0009892 | negative regulation of metabolic process | 19.05% (16/84) | 3.04 | 0.0 | 0.0 |
GO:0006305 | DNA alkylation | 11.9% (10/84) | 4.27 | 0.0 | 0.0 |
GO:0006306 | DNA methylation | 11.9% (10/84) | 4.27 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 48.81% (41/84) | 1.4 | 0.0 | 0.0 |
GO:0006310 | DNA recombination | 11.9% (10/84) | 3.8 | 0.0 | 0.0 |
GO:0043412 | macromolecule modification | 27.38% (23/84) | 2.04 | 0.0 | 0.0 |
GO:0036211 | protein modification process | 23.81% (20/84) | 2.14 | 0.0 | 0.0 |
GO:0006464 | cellular protein modification process | 23.81% (20/84) | 2.14 | 0.0 | 0.0 |
GO:0005634 | nucleus | 63.1% (53/84) | 0.91 | 0.0 | 1e-06 |
GO:0044237 | cellular metabolic process | 53.57% (45/84) | 1.08 | 0.0 | 1e-06 |
GO:1903046 | meiotic cell cycle process | 10.71% (9/84) | 3.61 | 0.0 | 1e-06 |
GO:0071704 | organic substance metabolic process | 53.57% (45/84) | 1.02 | 0.0 | 2e-06 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 9.52% (8/84) | 3.82 | 0.0 | 2e-06 |
GO:0000910 | cytokinesis | 9.52% (8/84) | 3.79 | 0.0 | 2e-06 |
GO:0009909 | regulation of flower development | 11.9% (10/84) | 3.21 | 0.0 | 2e-06 |
GO:0022414 | reproductive process | 27.38% (23/84) | 1.76 | 0.0 | 2e-06 |
GO:0044238 | primary metabolic process | 48.81% (41/84) | 1.09 | 0.0 | 3e-06 |
GO:0048831 | regulation of shoot system development | 11.9% (10/84) | 3.15 | 0.0 | 3e-06 |
GO:0009560 | embryo sac egg cell differentiation | 8.33% (7/84) | 4.06 | 0.0 | 3e-06 |
GO:0006261 | DNA-dependent DNA replication | 9.52% (8/84) | 3.68 | 0.0 | 3e-06 |
GO:0048449 | floral organ formation | 8.33% (7/84) | 4.04 | 0.0 | 4e-06 |
GO:0048519 | negative regulation of biological process | 19.05% (16/84) | 2.17 | 0.0 | 6e-06 |
GO:0051276 | chromosome organization | 9.52% (8/84) | 3.54 | 0.0 | 7e-06 |
GO:0008283 | cell population proliferation | 8.33% (7/84) | 3.84 | 1e-06 | 9e-06 |
GO:2000241 | regulation of reproductive process | 11.9% (10/84) | 2.94 | 1e-06 | 1e-05 |
GO:0044267 | cellular protein metabolic process | 23.81% (20/84) | 1.8 | 1e-06 | 1e-05 |
GO:0008152 | metabolic process | 53.57% (45/84) | 0.91 | 1e-06 | 1.7e-05 |
GO:0006270 | DNA replication initiation | 5.95% (5/84) | 4.66 | 2e-06 | 2.2e-05 |
GO:0000911 | cytokinesis by cell plate formation | 8.33% (7/84) | 3.62 | 2e-06 | 2.2e-05 |
GO:0003777 | microtubule motor activity | 5.95% (5/84) | 4.64 | 2e-06 | 2.3e-05 |
GO:0048580 | regulation of post-embryonic development | 11.9% (10/84) | 2.79 | 2e-06 | 2.3e-05 |
GO:0009987 | cellular process | 61.9% (52/84) | 0.76 | 2e-06 | 2.4e-05 |
GO:0060255 | regulation of macromolecule metabolic process | 26.19% (22/84) | 1.59 | 2e-06 | 2.4e-05 |
GO:2000026 | regulation of multicellular organismal development | 11.9% (10/84) | 2.77 | 2e-06 | 2.5e-05 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 10.71% (9/84) | 2.98 | 2e-06 | 2.6e-05 |
GO:1905393 | plant organ formation | 8.33% (7/84) | 3.57 | 2e-06 | 2.6e-05 |
GO:0006974 | cellular response to DNA damage stimulus | 9.52% (8/84) | 3.16 | 3e-06 | 3.8e-05 |
GO:0006275 | regulation of DNA replication | 7.14% (6/84) | 3.88 | 3e-06 | 4e-05 |
GO:0140527 | reciprocal homologous recombination | 7.14% (6/84) | 3.86 | 4e-06 | 4.2e-05 |
GO:0007131 | reciprocal meiotic recombination | 7.14% (6/84) | 3.86 | 4e-06 | 4.2e-05 |
GO:0051239 | regulation of multicellular organismal process | 11.9% (10/84) | 2.67 | 4e-06 | 4.4e-05 |
GO:0035825 | homologous recombination | 7.14% (6/84) | 3.84 | 4e-06 | 4.5e-05 |
GO:0007129 | homologous chromosome pairing at meiosis | 5.95% (5/84) | 4.36 | 5e-06 | 5e-05 |
GO:0070192 | chromosome organization involved in meiotic cell cycle | 5.95% (5/84) | 4.31 | 6e-06 | 5.9e-05 |
GO:0003774 | cytoskeletal motor activity | 5.95% (5/84) | 4.29 | 6e-06 | 6.1e-05 |
GO:0034645 | cellular macromolecule biosynthetic process | 17.86% (15/84) | 1.95 | 6e-06 | 6.7e-05 |
GO:0034971 | histone H3-R17 methylation | 2.38% (2/84) | 8.36 | 9e-06 | 9.1e-05 |
GO:0034970 | histone H3-R2 methylation | 2.38% (2/84) | 8.36 | 9e-06 | 9.1e-05 |
GO:0034972 | histone H3-R26 methylation | 2.38% (2/84) | 8.36 | 9e-06 | 9.1e-05 |
GO:0031047 | gene silencing by RNA | 7.14% (6/84) | 3.63 | 1e-05 | 9.4e-05 |
GO:0019222 | regulation of metabolic process | 26.19% (22/84) | 1.41 | 1.5e-05 | 0.000147 |
GO:0005488 | binding | 41.67% (35/84) | 0.98 | 1.6e-05 | 0.000155 |
GO:0010267 | production of ta-siRNAs involved in RNA interference | 5.95% (5/84) | 3.89 | 2.3e-05 | 0.000215 |
GO:0140657 | ATP-dependent activity | 9.52% (8/84) | 2.77 | 2.3e-05 | 0.000217 |
GO:0019538 | protein metabolic process | 25.0% (21/84) | 1.41 | 2.5e-05 | 0.000229 |
GO:0035241 | protein-arginine omega-N monomethyltransferase activity | 2.38% (2/84) | 7.78 | 2.7e-05 | 0.000234 |
GO:0035279 | mRNA cleavage involved in gene silencing by miRNA | 2.38% (2/84) | 7.78 | 2.7e-05 | 0.000234 |
GO:0016277 | [myelin basic protein]-arginine N-methyltransferase activity | 2.38% (2/84) | 7.78 | 2.7e-05 | 0.000234 |
GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity | 2.38% (2/84) | 7.78 | 2.7e-05 | 0.000234 |
GO:0008469 | histone-arginine N-methyltransferase activity | 2.38% (2/84) | 7.78 | 2.7e-05 | 0.000234 |
GO:0035246 | peptidyl-arginine N-methylation | 2.38% (2/84) | 7.78 | 2.7e-05 | 0.000234 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 2.38% (2/84) | 7.78 | 2.7e-05 | 0.000234 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 2.38% (2/84) | 7.78 | 2.7e-05 | 0.000234 |
GO:0009059 | macromolecule biosynthetic process | 17.86% (15/84) | 1.76 | 3e-05 | 0.00025 |
GO:0051726 | regulation of cell cycle | 8.33% (7/84) | 2.99 | 3e-05 | 0.000253 |
GO:0003006 | developmental process involved in reproduction | 20.24% (17/84) | 1.59 | 3.8e-05 | 0.000316 |
GO:0005515 | protein binding | 21.43% (18/84) | 1.52 | 3.8e-05 | 0.000318 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 8.33% (7/84) | 2.92 | 4e-05 | 0.000324 |
GO:0035196 | production of miRNAs involved in gene silencing by miRNA | 5.95% (5/84) | 3.68 | 4.5e-05 | 0.000365 |
GO:0034969 | histone arginine methylation | 2.38% (2/84) | 7.36 | 5.4e-05 | 0.000431 |
GO:0010589 | leaf proximal/distal pattern formation | 2.38% (2/84) | 7.36 | 5.4e-05 | 0.000431 |
GO:0008168 | methyltransferase activity | 5.95% (5/84) | 3.6 | 6e-05 | 0.000474 |
GO:0050793 | regulation of developmental process | 13.1% (11/84) | 2.05 | 6.6e-05 | 0.000509 |
GO:0010305 | leaf vascular tissue pattern formation | 3.57% (3/84) | 5.25 | 6.7e-05 | 0.000514 |
GO:0048453 | sepal formation | 4.76% (4/84) | 4.19 | 7e-05 | 0.000517 |
GO:0048451 | petal formation | 4.76% (4/84) | 4.19 | 7e-05 | 0.000517 |
GO:0016070 | RNA metabolic process | 16.67% (14/84) | 1.74 | 6.9e-05 | 0.000523 |
GO:0030422 | production of siRNA involved in RNA interference | 5.95% (5/84) | 3.56 | 6.9e-05 | 0.000524 |
GO:0070918 | production of small RNA involved in gene silencing by RNA | 5.95% (5/84) | 3.52 | 7.7e-05 | 0.000559 |
GO:0031050 | dsRNA processing | 5.95% (5/84) | 3.52 | 7.7e-05 | 0.000559 |
GO:0051052 | regulation of DNA metabolic process | 4.76% (4/84) | 4.13 | 8.2e-05 | 0.000591 |
GO:0010468 | regulation of gene expression | 21.43% (18/84) | 1.44 | 8.4e-05 | 0.000596 |
GO:0016043 | cellular component organization | 22.62% (19/84) | 1.38 | 8.4e-05 | 0.000599 |
GO:0018195 | peptidyl-arginine modification | 2.38% (2/84) | 7.04 | 9.1e-05 | 0.000613 |
GO:0045003 | double-strand break repair via synthesis-dependent strand annealing | 2.38% (2/84) | 7.04 | 9.1e-05 | 0.000613 |
GO:0016274 | protein-arginine N-methyltransferase activity | 2.38% (2/84) | 7.04 | 9.1e-05 | 0.000613 |
GO:0016273 | arginine N-methyltransferase activity | 2.38% (2/84) | 7.04 | 9.1e-05 | 0.000613 |
GO:0006379 | mRNA cleavage | 2.38% (2/84) | 7.04 | 9.1e-05 | 0.000613 |
GO:0018216 | peptidyl-arginine methylation | 2.38% (2/84) | 7.04 | 9.1e-05 | 0.000613 |
GO:0051607 | defense response to virus | 5.95% (5/84) | 3.45 | 9.9e-05 | 0.00066 |
GO:0140546 | defense response to symbiont | 5.95% (5/84) | 3.45 | 9.9e-05 | 0.00066 |
GO:0016741 | transferase activity, transferring one-carbon groups | 5.95% (5/84) | 3.44 | 0.000102 | 0.000675 |
GO:0006281 | DNA repair | 7.14% (6/84) | 2.99 | 0.000113 | 0.000743 |
GO:0006996 | organelle organization | 15.48% (13/84) | 1.74 | 0.000123 | 0.000803 |
GO:1901363 | heterocyclic compound binding | 25.0% (21/84) | 1.24 | 0.000132 | 0.000849 |
GO:0097159 | organic cyclic compound binding | 25.0% (21/84) | 1.23 | 0.000144 | 0.000923 |
GO:0050789 | regulation of biological process | 33.33% (28/84) | 0.99 | 0.000155 | 0.000984 |
GO:0033043 | regulation of organelle organization | 5.95% (5/84) | 3.28 | 0.000173 | 0.001089 |
GO:1903047 | mitotic cell cycle process | 3.57% (3/84) | 4.74 | 0.000195 | 0.001221 |
GO:0032502 | developmental process | 27.38% (23/84) | 1.12 | 0.000201 | 0.001251 |
GO:0009615 | response to virus | 5.95% (5/84) | 3.19 | 0.000231 | 0.001425 |
GO:0010051 | xylem and phloem pattern formation | 4.76% (4/84) | 3.72 | 0.000249 | 0.001523 |
GO:0071840 | cellular component organization or biogenesis | 22.62% (19/84) | 1.26 | 0.000259 | 0.001577 |
GO:0048869 | cellular developmental process | 10.71% (9/84) | 2.08 | 0.000284 | 0.001712 |
GO:0051225 | spindle assembly | 3.57% (3/84) | 4.42 | 0.000373 | 0.002238 |
GO:0043229 | intracellular organelle | 78.57% (66/84) | 0.37 | 0.000391 | 0.002325 |
GO:0043226 | organelle | 78.57% (66/84) | 0.37 | 0.000396 | 0.002342 |
GO:0140694 | non-membrane-bounded organelle assembly | 3.57% (3/84) | 4.36 | 0.000424 | 0.002468 |
GO:0007051 | spindle organization | 3.57% (3/84) | 4.36 | 0.000424 | 0.002468 |
GO:0070925 | organelle assembly | 3.57% (3/84) | 4.33 | 0.00045 | 0.002605 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 9.52% (8/84) | 2.12 | 0.000513 | 0.002949 |
GO:0043247 | telomere maintenance in response to DNA damage | 3.57% (3/84) | 4.25 | 0.000537 | 0.003062 |
GO:0003676 | nucleic acid binding | 19.05% (16/84) | 1.31 | 0.000575 | 0.003261 |
GO:0006396 | RNA processing | 10.71% (9/84) | 1.92 | 0.000607 | 0.003373 |
GO:0032204 | regulation of telomere maintenance | 3.57% (3/84) | 4.19 | 0.0006 | 0.003376 |
GO:0043231 | intracellular membrane-bounded organelle | 77.38% (65/84) | 0.37 | 0.000606 | 0.003388 |
GO:0043227 | membrane-bounded organelle | 77.38% (65/84) | 0.36 | 0.000614 | 0.00339 |
GO:0033044 | regulation of chromosome organization | 4.76% (4/84) | 3.36 | 0.000635 | 0.003435 |
GO:0007059 | chromosome segregation | 4.76% (4/84) | 3.36 | 0.000635 | 0.003435 |
GO:0110165 | cellular anatomical entity | 96.43% (81/84) | 0.19 | 0.000627 | 0.003437 |
GO:0006312 | mitotic recombination | 3.57% (3/84) | 4.12 | 0.000703 | 0.003779 |
GO:0000226 | microtubule cytoskeleton organization | 5.95% (5/84) | 2.78 | 0.000835 | 0.004461 |
GO:0016572 | histone phosphorylation | 3.57% (3/84) | 3.99 | 0.000898 | 0.004711 |
GO:0032200 | telomere organization | 3.57% (3/84) | 3.99 | 0.000898 | 0.004711 |
GO:0000723 | telomere maintenance | 3.57% (3/84) | 3.99 | 0.000898 | 0.004711 |
GO:0016779 | nucleotidyltransferase activity | 4.76% (4/84) | 3.21 | 0.000935 | 0.004873 |
GO:0000280 | nuclear division | 3.57% (3/84) | 3.97 | 0.000941 | 0.004875 |
GO:0065007 | biological regulation | 33.33% (28/84) | 0.84 | 0.000951 | 0.004896 |
GO:0010564 | regulation of cell cycle process | 4.76% (4/84) | 3.2 | 0.00096 | 0.00491 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 3.57% (3/84) | 3.95 | 0.000985 | 0.00498 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 3.57% (3/84) | 3.95 | 0.000985 | 0.00498 |
GO:0051169 | nuclear transport | 4.76% (4/84) | 3.15 | 0.00109 | 0.005318 |
GO:0006913 | nucleocytoplasmic transport | 4.76% (4/84) | 3.15 | 0.00109 | 0.005318 |
GO:0042054 | histone methyltransferase activity | 2.38% (2/84) | 5.36 | 0.001064 | 0.005346 |
GO:0000724 | double-strand break repair via homologous recombination | 3.57% (3/84) | 3.9 | 0.001078 | 0.005349 |
GO:0000725 | recombinational repair | 3.57% (3/84) | 3.9 | 0.001078 | 0.005349 |
GO:0030154 | cell differentiation | 8.33% (7/84) | 2.14 | 0.001085 | 0.005355 |
GO:0007017 | microtubule-based process | 5.95% (5/84) | 2.67 | 0.001172 | 0.005683 |
GO:0016441 | posttranscriptional gene silencing | 4.76% (4/84) | 3.1 | 0.001263 | 0.006089 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 3.57% (3/84) | 3.82 | 0.001278 | 0.006126 |
GO:1901564 | organonitrogen compound metabolic process | 27.38% (23/84) | 0.93 | 0.001333 | 0.006355 |
GO:1901987 | regulation of cell cycle phase transition | 3.57% (3/84) | 3.76 | 0.001442 | 0.006837 |
GO:0051128 | regulation of cellular component organization | 5.95% (5/84) | 2.59 | 0.001478 | 0.006968 |
GO:0016569 | obsolete covalent chromatin modification | 2.38% (2/84) | 5.12 | 0.001507 | 0.007066 |
GO:0010332 | response to gamma radiation | 3.57% (3/84) | 3.72 | 0.001559 | 0.007267 |
GO:0009954 | proximal/distal pattern formation | 2.38% (2/84) | 5.04 | 0.001672 | 0.007749 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 2.38% (2/84) | 4.9 | 0.002024 | 0.009281 |
GO:0009886 | post-embryonic animal morphogenesis | 2.38% (2/84) | 4.9 | 0.002024 | 0.009281 |
GO:0010228 | vegetative to reproductive phase transition of meristem | 5.95% (5/84) | 2.47 | 0.002167 | 0.009879 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 3.57% (3/84) | 3.5 | 0.002384 | 0.010813 |
GO:0017076 | purine nucleotide binding | 8.33% (7/84) | 1.92 | 0.002567 | 0.011457 |
GO:0032555 | purine ribonucleotide binding | 8.33% (7/84) | 1.92 | 0.002544 | 0.011475 |
GO:0003002 | regionalization | 4.76% (4/84) | 2.82 | 0.002563 | 0.011501 |
GO:0008170 | N-methyltransferase activity | 2.38% (2/84) | 4.72 | 0.002614 | 0.011602 |
GO:0032553 | ribonucleotide binding | 8.33% (7/84) | 1.91 | 0.002686 | 0.011862 |
GO:0008276 | protein methyltransferase activity | 2.38% (2/84) | 4.66 | 0.002826 | 0.012413 |
GO:0010212 | response to ionizing radiation | 3.57% (3/84) | 3.41 | 0.002881 | 0.01259 |
GO:0048285 | organelle fission | 3.57% (3/84) | 3.38 | 0.00306 | 0.012646 |
GO:0009933 | meristem structural organization | 3.57% (3/84) | 3.38 | 0.00306 | 0.012646 |
GO:0030620 | U2 snRNA binding | 1.19% (1/84) | 8.36 | 0.003037 | 0.012679 |
GO:0031054 | pre-miRNA processing | 1.19% (1/84) | 8.36 | 0.003037 | 0.012679 |
GO:1990817 | RNA adenylyltransferase activity | 1.19% (1/84) | 8.36 | 0.003037 | 0.012679 |
GO:0004810 | tRNA adenylyltransferase activity | 1.19% (1/84) | 8.36 | 0.003037 | 0.012679 |
GO:0017069 | snRNA binding | 1.19% (1/84) | 8.36 | 0.003037 | 0.012679 |
GO:0030619 | U1 snRNA binding | 1.19% (1/84) | 8.36 | 0.003037 | 0.012679 |
GO:0010425 | DNA methylation on cytosine within a CNG sequence | 1.19% (1/84) | 8.36 | 0.003037 | 0.012679 |
GO:0004835 | tubulin-tyrosine ligase activity | 1.19% (1/84) | 8.36 | 0.003037 | 0.012679 |
GO:0097367 | carbohydrate derivative binding | 8.33% (7/84) | 1.88 | 0.002937 | 0.012768 |
GO:0019200 | carbohydrate kinase activity | 2.38% (2/84) | 4.56 | 0.003274 | 0.013464 |
GO:0048532 | anatomical structure arrangement | 3.57% (3/84) | 3.29 | 0.003636 | 0.014809 |
GO:0009616 | RNAi-mediated antiviral immune response | 3.57% (3/84) | 3.29 | 0.003636 | 0.014809 |
GO:0007346 | regulation of mitotic cell cycle | 3.57% (3/84) | 3.28 | 0.003738 | 0.015152 |
GO:0009887 | animal organ morphogenesis | 3.57% (3/84) | 3.26 | 0.003842 | 0.015497 |
GO:0006302 | double-strand break repair | 3.57% (3/84) | 3.25 | 0.003948 | 0.015847 |
GO:0007267 | cell-cell signaling | 3.57% (3/84) | 3.23 | 0.004055 | 0.0162 |
GO:0023052 | signaling | 3.57% (3/84) | 3.22 | 0.004164 | 0.016557 |
GO:0140097 | catalytic activity, acting on DNA | 3.57% (3/84) | 3.18 | 0.004502 | 0.017816 |
GO:0003723 | RNA binding | 7.14% (6/84) | 1.94 | 0.004796 | 0.01889 |
GO:0010608 | posttranscriptional regulation of gene expression | 4.76% (4/84) | 2.54 | 0.005109 | 0.020032 |
GO:0007010 | cytoskeleton organization | 5.95% (5/84) | 2.17 | 0.005135 | 0.020037 |
GO:0140098 | catalytic activity, acting on RNA | 4.76% (4/84) | 2.53 | 0.005189 | 0.020154 |
GO:0044839 | cell cycle G2/M phase transition | 1.19% (1/84) | 7.36 | 0.006066 | 0.022518 |
GO:0010069 | zygote asymmetric cytokinesis in embryo sac | 1.19% (1/84) | 7.36 | 0.006066 | 0.022518 |
GO:0008574 | plus-end-directed microtubule motor activity | 1.19% (1/84) | 7.36 | 0.006066 | 0.022518 |
GO:0000281 | mitotic cytokinesis | 1.19% (1/84) | 7.36 | 0.006066 | 0.022518 |
GO:0042276 | error-prone translesion synthesis | 1.19% (1/84) | 7.36 | 0.006066 | 0.022518 |
GO:0000404 | heteroduplex DNA loop binding | 1.19% (1/84) | 7.36 | 0.006066 | 0.022518 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.19% (1/84) | 7.36 | 0.006066 | 0.022518 |
GO:0005815 | microtubule organizing center | 1.19% (1/84) | 7.36 | 0.006066 | 0.022518 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 3.57% (3/84) | 3.04 | 0.00588 | 0.022735 |
GO:0009855 | determination of bilateral symmetry | 3.57% (3/84) | 3.02 | 0.006155 | 0.022749 |
GO:0009799 | specification of symmetry | 3.57% (3/84) | 3.01 | 0.006295 | 0.023165 |
GO:0006955 | immune response | 4.76% (4/84) | 2.47 | 0.006029 | 0.023202 |
GO:0009888 | tissue development | 4.76% (4/84) | 2.44 | 0.006481 | 0.023744 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 3.57% (3/84) | 2.89 | 0.007803 | 0.02834 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 3.57% (3/84) | 2.89 | 0.007803 | 0.02834 |
GO:0044249 | cellular biosynthetic process | 22.62% (19/84) | 0.84 | 0.00799 | 0.028648 |
GO:0006220 | pyrimidine nucleotide metabolic process | 3.57% (3/84) | 2.88 | 0.007964 | 0.028678 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 3.57% (3/84) | 2.88 | 0.007964 | 0.028678 |
GO:0046982 | protein heterodimerization activity | 2.38% (2/84) | 3.87 | 0.008292 | 0.029606 |
GO:0042991 | obsolete transcription factor import into nucleus | 2.38% (2/84) | 3.84 | 0.008652 | 0.03076 |
GO:0005669 | transcription factor TFIID complex | 1.19% (1/84) | 6.78 | 0.009085 | 0.031111 |
GO:0080111 | DNA demethylation | 1.19% (1/84) | 6.78 | 0.009085 | 0.031111 |
GO:0004652 | polynucleotide adenylyltransferase activity | 1.19% (1/84) | 6.78 | 0.009085 | 0.031111 |
GO:0010445 | nuclear dicing body | 1.19% (1/84) | 6.78 | 0.009085 | 0.031111 |
GO:0019985 | translesion synthesis | 1.19% (1/84) | 6.78 | 0.009085 | 0.031111 |
GO:0010070 | zygote asymmetric cell division | 1.19% (1/84) | 6.78 | 0.009085 | 0.031111 |
GO:0080175 | phragmoplast microtubule organization | 1.19% (1/84) | 6.78 | 0.009085 | 0.031111 |
GO:0035510 | DNA dealkylation | 1.19% (1/84) | 6.78 | 0.009085 | 0.031111 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 3.57% (3/84) | 2.82 | 0.008974 | 0.031769 |
GO:0035639 | purine ribonucleoside triphosphate binding | 7.14% (6/84) | 1.73 | 0.0097 | 0.033081 |
GO:0009524 | phragmoplast | 2.38% (2/84) | 3.75 | 0.009773 | 0.033198 |
GO:0008150 | biological_process | 85.71% (72/84) | 0.2 | 0.009843 | 0.033299 |
GO:0018130 | heterocycle biosynthetic process | 9.52% (8/84) | 1.42 | 0.010167 | 0.034121 |
GO:0005635 | nuclear envelope | 2.38% (2/84) | 3.72 | 0.010161 | 0.034237 |
GO:0009165 | nucleotide biosynthetic process | 4.76% (4/84) | 2.23 | 0.010537 | 0.035223 |
GO:1901293 | nucleoside phosphate biosynthetic process | 4.76% (4/84) | 2.23 | 0.010665 | 0.035509 |
GO:0048481 | plant ovule development | 3.57% (3/84) | 2.71 | 0.011013 | 0.036522 |
GO:0072527 | pyrimidine-containing compound metabolic process | 3.57% (3/84) | 2.69 | 0.01141 | 0.037541 |
GO:0042802 | identical protein binding | 3.57% (3/84) | 2.69 | 0.01141 | 0.037541 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.19% (1/84) | 6.36 | 0.012095 | 0.039181 |
GO:0010338 | leaf formation | 1.19% (1/84) | 6.36 | 0.012095 | 0.039181 |
GO:0061640 | cytoskeleton-dependent cytokinesis | 1.19% (1/84) | 6.36 | 0.012095 | 0.039181 |
GO:0005737 | cytoplasm | 21.43% (18/84) | 0.81 | 0.012028 | 0.039419 |
GO:0032559 | adenyl ribonucleotide binding | 5.95% (5/84) | 1.86 | 0.012373 | 0.039773 |
GO:0030554 | adenyl nucleotide binding | 5.95% (5/84) | 1.86 | 0.012373 | 0.039773 |
GO:0010074 | maintenance of meristem identity | 2.38% (2/84) | 3.56 | 0.012625 | 0.040273 |
GO:0048507 | meristem development | 2.38% (2/84) | 3.56 | 0.012625 | 0.040273 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 2.38% (2/84) | 3.53 | 0.013058 | 0.041499 |
GO:0000278 | mitotic cell cycle | 3.57% (3/84) | 2.61 | 0.013299 | 0.042104 |
GO:0005575 | cellular_component | 96.43% (81/84) | 0.12 | 0.013711 | 0.043247 |
GO:1901265 | nucleoside phosphate binding | 8.33% (7/84) | 1.45 | 0.014307 | 0.044789 |
GO:0000166 | nucleotide binding | 8.33% (7/84) | 1.45 | 0.014307 | 0.044789 |
GO:0032135 | DNA insertion or deletion binding | 1.19% (1/84) | 6.04 | 0.015096 | 0.04556 |
GO:0001872 | (1->3)-beta-D-glucan binding | 1.19% (1/84) | 6.04 | 0.015096 | 0.04556 |
GO:0009008 | DNA-methyltransferase activity | 1.19% (1/84) | 6.04 | 0.015096 | 0.04556 |
GO:0003886 | DNA (cytosine-5-)-methyltransferase activity | 1.19% (1/84) | 6.04 | 0.015096 | 0.04556 |
GO:0009652 | thigmotropism | 1.19% (1/84) | 6.04 | 0.015096 | 0.04556 |
GO:0043570 | maintenance of DNA repeat elements | 1.19% (1/84) | 6.04 | 0.015096 | 0.04556 |
GO:0035198 | miRNA binding | 1.19% (1/84) | 6.04 | 0.015096 | 0.04556 |
GO:0006282 | regulation of DNA repair | 1.19% (1/84) | 6.04 | 0.015096 | 0.04556 |
GO:0006406 | mRNA export from nucleus | 2.38% (2/84) | 3.43 | 0.014856 | 0.046164 |
GO:0051028 | mRNA transport | 2.38% (2/84) | 3.43 | 0.014856 | 0.046164 |
GO:0010014 | meristem initiation | 3.57% (3/84) | 2.53 | 0.015355 | 0.046176 |
GO:0097747 | RNA polymerase activity | 2.38% (2/84) | 3.39 | 0.015793 | 0.046986 |
GO:0034062 | 5'-3' RNA polymerase activity | 2.38% (2/84) | 3.39 | 0.015793 | 0.046986 |
GO:0004386 | helicase activity | 2.38% (2/84) | 3.39 | 0.015793 | 0.046986 |
GO:0043168 | anion binding | 7.14% (6/84) | 1.57 | 0.016016 | 0.047483 |
GO:0051130 | positive regulation of cellular component organization | 2.38% (2/84) | 3.36 | 0.01627 | 0.047898 |
GO:0010638 | positive regulation of organelle organization | 2.38% (2/84) | 3.36 | 0.01627 | 0.047898 |
GO:0006351 | transcription, DNA-templated | 3.57% (3/84) | 2.49 | 0.016571 | 0.048275 |
GO:0097659 | nucleic acid-templated transcription | 3.57% (3/84) | 2.49 | 0.016571 | 0.048275 |
GO:0033554 | cellular response to stress | 9.52% (8/84) | 1.29 | 0.016476 | 0.048334 |
GO:0098727 | maintenance of cell number | 2.38% (2/84) | 3.34 | 0.016754 | 0.048471 |
GO:0019827 | stem cell population maintenance | 2.38% (2/84) | 3.34 | 0.016754 | 0.048471 |
GO:0046390 | ribose phosphate biosynthetic process | 3.57% (3/84) | 2.47 | 0.017072 | 0.049053 |
GO:0009260 | ribonucleotide biosynthetic process | 3.57% (3/84) | 2.47 | 0.017072 | 0.049053 |
GO:0050657 | nucleic acid transport | 2.38% (2/84) | 3.28 | 0.018242 | 0.049371 |
GO:0050658 | RNA transport | 2.38% (2/84) | 3.28 | 0.018242 | 0.049371 |
GO:0006405 | RNA export from nucleus | 2.38% (2/84) | 3.28 | 0.018242 | 0.049371 |
GO:0046658 | anchored component of plasma membrane | 2.38% (2/84) | 3.28 | 0.018242 | 0.049371 |
GO:0051236 | establishment of RNA localization | 2.38% (2/84) | 3.28 | 0.018242 | 0.049371 |
GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |
GO:0044770 | cell cycle phase transition | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |
GO:1901567 | fatty acid derivative binding | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |
GO:0032776 | DNA methylation on cytosine | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |
GO:0044772 | mitotic cell cycle phase transition | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |
GO:0120227 | acyl-CoA binding | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |
GO:0000062 | fatty-acyl-CoA binding | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |
GO:1902410 | mitotic cytokinetic process | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |
GO:1902407 | assembly of actomyosin apparatus involved in mitotic cytokinesis | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |
GO:0032506 | cytokinetic process | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |
GO:0000914 | phragmoplast assembly | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |
GO:0004396 | hexokinase activity | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |
GO:0000775 | chromosome, centromeric region | 1.19% (1/84) | 5.78 | 0.018088 | 0.049758 |